MIT scientists built over 400 tiny ecosystems with 12 to 20 bacterial species; after adding an outsider, the more changeable communities were easier to invade
Researchers at MIT have discovered that chaotic ecosystems easily accept new species while stable ones resist invasion. Conventional ecological beliefs suggest high biodiversity prevents invasions, but stability plays a crucial role. This finding ...

An AI-generated image of researchers conducting a large-scale microbial ecosystem experiment using hundreds of miniature laboratory cultures. Image credits: ChatGPT
Biodiversity was meant to protect you
Conventionally, ecologists would expect a highly biodiverse ecosystem to be the hardest to invade. With so many species present, there are fewer opportunities to exploit because the number of available niches is occupied. There is less available space for new species to exploit. However, the MIT team found that this is not always true. Real ecosystems such as coral reefs or grasslands do not always follow this logic.

Why your probiotic gummies may be a waste of money
The MIT researchers have said they now plan to test the invasion theory in the human gut microbiome, which could explain why some probiotics work and others do not. Earlier findings appear to support this idea. A 2018 Cell study led by Eran Elinav and Eran Segal at the Weizmann Institute, titled “Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features,” found that the effect of an 11-strain probiotic supplement varied widely from person to person, even though the strains were detected reliably in stool samples. Direct testing of the gut lining itself, however, told a different story: some individuals’ gut linings readily took up the new bacteria, while others’ showed little to no colonisation.

When it's actually useful
There is, however, a scenario where an unstable gut is exactly what’s needed: fecal microbiota transplants (FMT), used to displace a harmful resident species. FMT is now an FDA-approved treatment for recurrent C. difficile infections. A 2017 randomised clinical trial in JAMA, “Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection,” found that both capsule- and colonoscopy-delivered FMT resulted in approximately 90% of patients remaining free of relapse. In these cases, doctors are intentionally destabilising the gut ecosystem to let healthy donor bacteria take hold.
The main takeaway
Whilst none of this has been proven in real human guts, the formula the MIT team developed is based entirely on bacteria and soil. The researchers have said their next step is testing it in real-world ecosystems. That said, it is an uncomfortable finding for an entire industry built around increasing the number of bacteria in the gut. It seems that gut resilience may depend more on how stable the ecosystem is than on how much bacterial activity it contains.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.